Keyphrases
Acute Lymphoblastic Leukemia
100%
Chemotherapeutic Treatment
100%
Surfactant Protein D (SP-D)
100%
Circulating Levels
100%
Healthy Controls
18%
D-value
18%
Detrimental Effects
9%
Systemic Inflammation
9%
Immune Function
9%
Innate Immune Response
9%
Fever
9%
Interleukin-6
9%
Inflammatory Response
9%
White Blood Cells
9%
Host Defense
9%
Study Support
9%
C-reactive Protein
9%
Systemic Inflammatory Response
9%
Treatment Phase
9%
Antibiotics
9%
Pathogen Clearance
9%
Chemotherapy Initiation
9%
Induction Period
9%
Bacteremia
9%
Chemotherapy-induced
9%
Blood Draw
9%
Pharmacology, Toxicology and Pharmaceutical Science
Surfactant Protein D
100%
Acute Lymphoblastic Leukemia
100%
Inflammation
27%
Chemotherapy
27%
Mucosa Inflammation
18%
C Reactive Protein
9%
Antibiotics
9%
Interleukin 6
9%
Pathogen Clearance
9%
Prospective Study
9%
Bloodstream Infection
9%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Chemotherapy
100%
Mucositis
18%
Serositis
18%
Innate Immunity
9%
Prospective Study
9%
C Reactive Protein
9%
Leukocyte
9%
Host Resistance
9%
Interleukin 6
9%
Immune Function
9%
Antibiotics
9%
Bloodstream Infection
9%
Immunology and Microbiology
Surfactant Protein D
100%
Inflammation Response
18%
C-Reactive Protein
9%
Systemic Inflammation
9%
Interleukin 6
9%
Pathogen Clearance
9%
Innate Immune System
9%
Immunity
9%
Leukocyte
9%
Host Resistance
9%